isoxazoles has been researched along with Vascular Calcification in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konoplyannikov, M; Nurminskaya, M | 1 |
| Banyard, D; Beazley, KE; Deasey, SC; Konoplyannikov, M; Lima, F; Nurminskaya, MV; Nurminsky, DI | 1 |
1 review(s) available for isoxazoles and Vascular Calcification
| Article | Year |
|---|---|
New therapeutic approaches to arterial calcification via inhibition of transglutaminase and β-catenin signaling.
Topics: Animals; beta Catenin; Enzyme Inhibitors; Humans; Isoxazoles; Signal Transduction; Transglutaminases; Vascular Calcification | 2014 |
1 other study(ies) available for isoxazoles and Vascular Calcification
| Article | Year |
|---|---|
Transglutaminase inhibitors attenuate vascular calcification in a preclinical model.
Topics: Animals; Aorta; Aortic Diseases; beta Catenin; Blood Pressure; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; GTP-Binding Proteins; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Osteogenesis; Phosphorylation; Protein Glutamine gamma Glutamyltransferase 2; Quercetin; Rats; Rats, Wistar; Signal Transduction; Transglutaminases; Vascular Calcification; Warfarin | 2013 |